AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 29113968
Drug: norfloxacin (antibiotic)
RxNorm normalized name: Norfloxacin
DrugBank: Norfloxacin (DB01059)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: norfloxacin (antibiotic)
Trial: 26116627
Drug: Spironolactone (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone (12.5 mg titrated to 25 mg)
Trial: 21457929
Drug: Standard-fluence photodynamic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-fluence photodynamic therapy (PDT) at 50 J/cm²
Trial: 21457929
Drug: Low-fluence photodynamic
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fluence photodynamic therapy (PDT) at 25 J/cm²
Trial: 19344725
Drug: Single intranasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single intranasal dose of oxytocin
Trial: 17893153
Drug: Altastaph (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Altastaph (200 mg/kg in two infusions 24 hours apart)
Trial: 15761542
Drug: Prednisolone (PD)
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone (PD) 2.4-3.5 mg/m2 BSA
Trial: 15761542
Drug: Hydrocortisone (HC)
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hydrocortisone (HC) 10-15 mg/m2 BSA
Trial: 10803800
Drug: tolcapone 200
RxNorm normalized name: tolcapone 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tolcapone 200 mg three times daily
Trial: 2457422
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with cyclophosphamide, doxorubicin, vincristine, and methotrexate, alternating after four cycles with cyclophosphamide, lomustine, vincristine, and methotrexate + irradiation at 40 Gy
Trial: 2457422
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with cyclophosphamide, doxorubicin, vincristine, and methotrexate, alternating after four cycles with cyclophosphamide, lomustine, vincristine, and methotrexate
Trial: 25854013
Drug: Acupuncture-moxibustion +
RxNorm normalized name: BUTYLENE GLYCOL 0.2 g in 1 g CUTANEOUS TAPE [ShiZhenTaiYiTang Moxibustion Patch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture-moxibustion + Chinese medicine (group B)
Trial: 25854013
Drug: Clomiphene +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomiphene + acupuncture-moxibustion + Chinese medicine (group C)
Trial: 24058684
Drug: Caffeine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (5 mg.kg(‐1) of body weight)
Trial: 15307698
Drug: Xiaoyan Zhixue
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xiaoyan Zhixue Capsule (XYZXC)
Trial: 9259359
Drug: Sodium chloride
RxNorm normalized name: Sodium Chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium chloride pills (60 mEq of sodium per day)
Trial: 8481365
Drug: Doxorubicin (70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin (70 mg/m2)
Trial: 8481365
Drug: Epirubicin (70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epirubicin (70 mg/m2)
Trial: 8481365
Drug: Mitozantrone (14
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mitozantrone (14 mg/m2)
Trial: 3102153
Drug: Oral fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral fat
Trial: 3102153
Drug: Oral protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral protein
Trial: 3102153
Drug: Insulin‐induced hypoglycaemia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin‐induced hypoglycaemia
Trial: 3102153
Drug: Intravenous arginine
RxNorm normalized name: Arginine
DrugBank: Arginine (DB00125)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous arginine
Trial: 3102153
Drug: Oral carbohydrate
RxNorm normalized name: omega-3 carboxylic acids Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral carbohydrate
Trial: 28888220
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg immediate-release co-crystal of tramadol-celecoxib (CTC)
Trial: 28888220
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg immediate-release tramadol
Trial: 28888220
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg immediate-release tramadol and 100 mg celecoxib
Trial: 16308443
Drug: Plaferon LB
RxNorm normalized name: LB-100
DrugBank: LB-100 (DB15412)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plaferon LB (5 mg/ml - 3 ml daily inhalations)
Trial: 16308443
Drug: Placebo (inert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (inert solution)
Trial: 12531809
Drug: Dexamethasone (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (6 mg/m(2)/d for 28 days in induction, plus taper)
Trial: 12531809
Drug: Prednisone (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (40 mg/m(2)/d)
Trial: 12531809
Drug: Oral 6-mercaptopurine
RxNorm normalized name: 6-Mercaptopurine
DrugBank: Mercaptopurine (DB01033)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral 6-mercaptopurine
Trial: 14610016
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (no abciximab)
Trial: 9440388
Drug: High-RS diet
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-RS diet (amylomaize starch, 55.2 +/- 3.5 g RS/d)
Trial: 9440388
Drug: Low-RS diet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-RS diet (available cornstarch, 7.7 +/- 0.3 g RS/d)
Trial: 8591965
Drug: Prenephrectomy therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prenephrectomy therapy
Trial: 23455033
Drug: Abciximab and
RxNorm normalized name: Abciximab
DrugBank: Abciximab (DB00054)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Abciximab and heparin
Trial: 19587440
Drug: Tongxinluo (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tongxinluo (4 capsules once, 3 times per day)
Trial: 11778566
Drug: Prophylactic cranial
RxNorm normalized name: geranial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic cranial irradiation (PCI) at a dose of 25.2‐30.6 Gy
Trial: 28528536
Drug: R+D (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R+D (10 mL of 0.25% ropivacaine + 0.5μg/kg dexmedetomidine)
Trial: 28528536
Drug: R (10
RxNorm normalized name: Avar (10 % / 5 % ) Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R (10 mL of 0.25% ropivacaine)
Trial: 27224446
Drug: Intravenous aspirin
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous aspirin (ASA) 100mg per day
Trial: 27224446
Drug: Oral aspirin
RxNorm normalized name: aspirin Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral aspirin (ASA) 100mg per day via gastric tube
Trial: 27224446
Drug: Overall response
RxNorm normalized name: Besponsa
DrugBank: Inotuzumab ozogamicin (DB05889)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Overall response to aspirin (both IV and oral)
Trial: 25222173
Drug: Increase in
RxNorm normalized name: Incruse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increase in Perceived Vulnerability (PV) from baseline to end of treatment
Trial: 10390223
Drug: Amprenavir (141W94)
DrugBank: Amprenavir (DB00701)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Amprenavir (141W94) 150 mg
Trial: 10390223
Drug: Amprenavir (141W94)
DrugBank: Amprenavir (DB00701)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Amprenavir (141W94) 300 mg
Trial: 10390223
Drug: Amprenavir (141W94)
DrugBank: Amprenavir (DB00701)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Amprenavir (141W94) 600 mg
Trial: 10390223
Drug: Amprenavir (141W94)
DrugBank: Amprenavir (DB00701)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Amprenavir (141W94) 900 mg
Trial: 10390223
Drug: Amprenavir (141W94)
DrugBank: Amprenavir (DB00701)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Amprenavir (141W94) 1200 mg
Trial: 10390223
Drug: Soft gelatin
RxNorm normalized name: Norvir Soft Gelatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soft gelatin capsule of amprenavir
Trial: 25276591
Drug: Oral amoxicillin
RxNorm normalized name: amoxicillin Oral Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral amoxicillin administered by traditional birth attendants (TBAs)
Trial: 25276591
Drug: Referral and/or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Referral and/or initiation of antibiotics
Trial: 11974558
Drug: 17 beta-estradiol/levonorgestrel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17 beta-estradiol/levonorgestrel 50/10 micrograms/24 h patch
Trial: 11974558
Drug: 17 beta-estradiol/levonorgestrel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17 beta-estradiol/levonorgestrel 75/15 micrograms/24 h patch
Trial: 11974558
Drug: 17 beta-estradiol/levonorgestrel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17 beta-estradiol/levonorgestrel 100/20 micrograms/24 h patch
Trial: 9784666
Drug: EPO treatment
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EPO treatment in iron-depleted patients
Trial: 9784666
Drug: EPO therapy
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EPO therapy in iron-replete patients
Trial: 7572595
Drug: Diltiazem controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem controlled diffusion (CD) 300 mg
Trial: 2258341
Drug: Pefloxacin (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pefloxacin (800 mg single dose)
Trial: 2258341
Drug: Co-trimoxazole (960
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-trimoxazole (960 mg twice daily for 5 days)
Trial: 7273010
Drug: Weekly regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly regimen of PALA and 5-FU (24 patients)
Trial: 21422852
Drug: Nutritional management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional management with self blood glucose monitoring and insulin as needed
Trial: 19272069
Drug: Postoperative low-molecular-weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative low-molecular-weight heparin (LMWH)
Trial: 19272069
Drug: No postoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No postoperative low-molecular-weight heparin (LMWH)
Trial: 8791885
Drug: Tretinoin 0.05%
RxNorm normalized name: TRETINOIN 0.05% CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tretinoin 0.05% emollient cream (Retinova ‐ Janssen‐Cilag Ltd)
Trial: 1826988
Drug: Epidural injection
RxNorm normalized name: Sufentanil Citrate 50 ug in 1 mL EPIDURAL INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural injection of 10-30 micrograms sufentanil added to 0.125% bupivacaine with epinephrine (1:800,000)
Trial: 1826988
Drug: Epidural injection
RxNorm normalized name: Sufentanil Citrate 50 ug in 1 mL EPIDURAL INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural injection of 0.125% bupivacaine with epinephrine (1:800,000) without sufentanil
Trial: 28619295
Drug: Massage therapy
RxNorm normalized name: CAMPHOR (SYNTHETIC) 30 g in 1 mL / MENTHOL 40 g in 1 mL TOPICAL OIL [CBDMEDIC MASSAGE THERAPY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Massage therapy (one hour a week during four weeks)
Trial: 12653169
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg zafirlukast b.i.d.
Trial: 10529020
Drug: Naltrexone with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone with buprenorphine taper (NB Group)
Trial: 10529020
Drug: Buprenorphine taper
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine taper alone followed by naltrexone (PB Group)
Trial: 10529020
Drug: Adjunct medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunct medication (clonidine)
Trial: 10529020
Drug: Sedatives (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sedatives (up to 20 mg diazepam)
Trial: 2032147
Drug: Alutard SQ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alutard SQ (grass pollen depot preparation)
Trial: 6354507
Drug: Mefloquine (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mefloquine (1000 mg given in one day)
Trial: 6354507
Drug: Chloroquine (1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroquine (1500 mg given over 3 days)
Trial: 27129120
Drug: Test product
RxNorm normalized name: Patch test product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test product (20 mg piroxicam capsule)
Trial: 27129120
Drug: Reference product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference product (20 mg piroxicam capsule)
Trial: 20646771
Drug: Honey dressing
RxNorm normalized name: MediHoney Dressing 3/4x12"
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Honey dressing applied to wounds for 3 months till healing, grafting or failure of treatment.
Trial: 17257466
Drug: Continuous combined
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous combined hormone replacement therapy (ccHRT) (Indivina)
Trial: 17257466
Drug: Lowest dose-combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lowest dose-combination of ccHRT
Trial: 6230174
Drug: Coumadin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coumadin treatment (prothrombin time 2 to 2.5 times the control value)
Trial: 6230174
Drug: Coumadin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coumadin treatment (for patients with at least a 6 month history of angina)
Trial: 6230174
Drug: Aspirin (for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (for patients with at least a 6 month history of angina)
Trial: 26306000
Drug: DBS plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DBS plus optimal drug therapy (DBS + ODT)
Trial: 27393540
Drug: Isoniazid prophylaxis
RxNorm normalized name: Isoniazid
DrugBank: Isoniazid (DB00951)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoniazid prophylaxis (exact dosage and duration not specified)
Trial: 18755319
Drug: Matching placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Matching placebo pills
Trial: 17458707
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of computer and paper-based CDSS
Trial: 15814548
Drug: Tacrolimus (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tacrolimus (0.2 mg/kg)
Trial: 15814548
Drug: Cyclosporin microemulsion
RxNorm normalized name: cyclosporine microemulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin microemulsion (7 mg/kg)
Trial: 1832761
Drug: atenolol 50
RxNorm normalized name: atenolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: atenolol 50 mg/day
Trial: 11910310
Drug: verapamil 180
RxNorm normalized name: verapamil 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: verapamil 180 + trandolapril 2 mg/day combination
Trial: 9426828
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg CPA
Trial: 9426828
Drug: CPA (10-150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPA (10-150 mg)
Trial: 8131255
Drug: Mefloquine in
RxNorm normalized name: Product containing mefloquine in oral dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mefloquine in combination with artesunate
Trial: 8131255
Drug: Artesunate effect
RxNorm normalized name: Artesunate
DrugBank: Artesunate (DB09274)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Artesunate effect on mefloquine pharmacokinetics
Trial: 31998472
Drug: Manual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy (MT) consisting of two high-velocity low-amplitude spinal manipulations and two grade IV mobilizations of the lumbar spine and pelvis
Trial: 25649543
Drug: Traumeel 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traumeel 2 ml injection
Trial: 25649543
Drug: Dexamethasone 8
RxNorm normalized name: dexamethasone 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 8 mg injection
Trial: 19165592
Drug: Child-focused cognitive
RxNorm normalized name: Senna-Relief Childs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Child-focused cognitive behavioral therapy (CCBT)
Trial: 17890444
Drug: Paroxetine 20
RxNorm normalized name: PARoxetine 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine 20 mg/day for 3 days before MDMA challenge (100 mg oral)
Trial: 10485505
Drug: Extended-release etodolac
RxNorm normalized name: etodolac Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release etodolac 1200 mg
Trial: 10485505
Drug: Conventional etodolac
RxNorm normalized name: Etodolac
DrugBank: Etodolac (DB00749)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional etodolac 400 mg
Trial: 10485505
Drug: Conventional etodolac
RxNorm normalized name: Etodolac
DrugBank: Etodolac (DB00749)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional etodolac 200 mg
Trial: 1773929
Drug: Hexetidine vaginal
RxNorm normalized name: Hexetidine
DrugBank: Hexetidine (DB08958)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hexetidine vaginal suppositories (10 mg) applied for five days
Trial: 1773929
Drug: Hexetidine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hexetidine (20 mg/day) applied for five days
Trial: 1773929
Drug: Hexetidine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hexetidine (10 mg/day) applied for three days pre-operatively
Trial: 1773929
Drug: Hexetidine preparation
RxNorm normalized name: Hexetidine
DrugBank: Hexetidine (DB08958)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hexetidine preparation
Trial: 27026043
Drug: Atorvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (40 mg/day) + Interferon beta-1a (30 micro g/week)
Trial: 27026043
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (Interferon beta-1a 30 micro g/week)
Trial: 19820906
Drug: Radiotherapy in
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Radiotherapy in combination with simultaneous chemotherapy
Trial: 19820906
Drug: Postoperative chemoradiation
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative chemoradiation and perioperative chemotherapy
Trial: 17255855
Drug: PEEP set
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PEEP set at 26 cm H2O and lung recruitment performed (40/40-maneuver) followed by tidal volume set at 4 mL/kg (T26R) and PEEP lowered by 2 cm H2O every 4 mins.
Trial: 17255855
Drug: PEEP set
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PEEP set at 26 cm H2O and lung recruitment performed (40/40-maneuver) followed by tidal volume set at 6 mL/kg (T(end)).
Trial: 11914251
Drug: CEE plus
RxNorm normalized name: Ecee Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEE plus MPA 2.5 mg
Trial: 11914251
Drug: CEE plus
RxNorm normalized name: Ecee Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEE plus MPA 5.0 mg
Trial: 11914251
Drug: CEE (0.625
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEE (0.625 mg)
Trial: 9210501
Drug: CsA (original
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CsA (original formulation)
Trial: 3621278
Drug: Antiarrhythmic drugs
RxNorm normalized name: ANTIARRHYTHMICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiarrhythmic drugs (two with class IC and two with class IA action)
Trial: 31055046
Drug: CALAS 20
RxNorm normalized name: CALASPARGASE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CALAS 20 mg
Trial: 31055046
Drug: CALAS 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CALAS 40 mg
Trial: 31055046
Drug: CALAS 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CALAS 80 mg
Trial: 31055046
Drug: CALAS 120
RxNorm normalized name: verapamil hydrochloride 120 MG [Calan]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CALAS 120 mg
Trial: 31055046
Drug: CALAS (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CALAS (all doses)
Trial: 24368613
Drug: Low-dose MBIR
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose MBIR
Trial: 24368613
Drug: Standard-dose FBP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose FBP
Trial: 23070400
Drug: Nabilone 0.5
RxNorm normalized name: nabilone 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nabilone 0.5 mg/day
Trial: 10095804
Drug: Folate administration
RxNorm normalized name: folate
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folate administration (0.25 mg day‐1) plus 60 mg day‐1 of Fe2+
Trial: 10095804
Drug: Placebo (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (60 mg day‐1 of Fe2+)
Trial: 7831065
Drug: TTFCA 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TTFCA 60 mg
Trial: 7831065
Drug: TTFCA 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TTFCA 120 mg
Trial: 3354874
Drug: Midazolam 0.1
RxNorm normalized name: midazolam 0.1 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.1 mg/kg IV
Trial: 3354874
Drug: Physostigmine 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physostigmine 2.0 mg IV